LP
KBIO

LMR Partners’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

LMR Partners’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,223
Closed -$58K – 589
2014
Q2 		$58K Buy
+3,223
New +$55.2K ﹤0.01% 448

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.45B AUM 5.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

LMR Partners's KBIO Position: Q3 2014 in Review

LMR Partners sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2014, closing a stake of 3,223 shares — an estimated $58K sold.

LMR Partners first reported a position in KBIO in Q2 2014 and held it in 1 quarter. The position peaked at $58K in Q2 2014. 35 funds tracked by Wall St. Rank hold KBIO as of Q3 2014.

  • LMR Partners reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2014 after selling out during the quarter.
  • LMR Partners sold 3,223 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2014, an estimated $58K.
  • LMR Partners first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2014 and held it in 1 quarter.
  • LMR Partners's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $58K in Q2 2014.
  • 35 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2014.

Based on LMR Partners's 13F filing for Q3 2014, filed 20 Oct 2014.